Literature DB >> 12498425

Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review.

Annick Delvigne1, Serge Rozenberg.   

Abstract

Ovarian hyperstimulation syndrome (OHSS) is a rare iatrogenic complication of ovarian stimulation occurring during the luteal phase or during early pregnancy. Fortunately, the reported prevalence of the severe form of OHSS is small, ranging from 0.5 to 5%. Nevertheless, as this is an iatrogenic complication of a non-vital treatment with a potentially fatal outcome, the syndrome remains a serious problem for specialists dealing with infertility. The aim of this literature review was to determine whether it is possible to identify patients at risk, and which preventive method should be applied when an exaggerated ovarian response occurs. Data pertaining to the epidemiology and prevention of OHSS in women were searched using Medline, Current Contents and PubMed, and are summarized. Preventive strategies attempt either to limit the dose or concentration of hCG or to find a way to induce luteolysis without inducing a detrimental effect on endometrial and oocyte quality. The following particular preventive strategies were reviewed: cancelling the cycle; coasting; early unilateral ovarian follicular aspiration (EUFA); modifying the methods of ovulation triggering; administration of glucocorticoids, macromolecules and progesterone; cryopreservation of all embryos; and electrocautery or laser vaporization of one or both ovaries.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12498425     DOI: 10.1093/humupd/8.6.559

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  120 in total

1.  Severe ovarian hyperstimulation syndrome after letrozole-gonadotropin stimulation: a case report.

Authors:  Jayeon Kim; Anne Z Steiner; Marc Fritz; Jennifer E Mersereau
Journal:  J Assist Reprod Genet       Date:  2011-11-17       Impact factor: 3.412

Review 2.  Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).

Authors:  Irene Kwan; Siladitya Bhattacharya; Angela Kang; Andrea Woolner
Journal:  Cochrane Database Syst Rev       Date:  2014-08-24

3.  No association between the microsatellite polymorphism (TTTTA)n in the promoter of the CYP11A gene and ovarian hyperstimulation syndrome.

Authors:  Polonca Ferk; Ksenija Gersak; Natasa Teran
Journal:  J Assist Reprod Genet       Date:  2006-01-04       Impact factor: 3.412

Review 4.  Understanding ovarian hyperstimulation syndrome.

Authors:  Anne Delbaere; Guillaume Smits; Anne De Leener; Sabine Costagliola; Gilbert Vassart
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

5.  Application of GnRH antagonist in combination with clomiphene citrate and hMG for patients with exaggerated ovarian response in previous IVF/ICSI cycles.

Authors:  Yu-Hung Lin; Kok-Min Seow; Bih-Chwen Hsieh; Lee-Wen Huang; Heng-Ju Chen; Shih-Chia Huang; Chih-Yu Chen; Pei-Hsin Chen; Jiann-Loung Hwang; Chi-Ruey Tzeng
Journal:  J Assist Reprod Genet       Date:  2007-07-17       Impact factor: 3.412

6.  A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.

Authors:  Yanett Anaya; Douglas A Mata; Joseph Letourneau; Hakan Cakmak; Marcelle I Cedars; Mitchell P Rosen
Journal:  J Assist Reprod Genet       Date:  2017-10-30       Impact factor: 3.412

7.  Could pretreatment with oral contraceptives before pituitary down regulation reduce the incidence of ovarian hyperstimulation syndrome in the IVF/ICSI procedure?

Authors:  Lan Wang; Yiqing Zhao; Xiyuan Dong; Kai Huang; Rui Wang; Licheng Ji; Ya Wang; Hanwang Zhang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

8.  Ovarian Hyperstimulation Syndrome (OHSS) Presented as Massive Hydrothorax.

Authors:  Pradip Kumar Saha; Poonam Goel; Rimpy Tandon
Journal:  J Clin Diagn Res       Date:  2013-12-15

9.  Do estrogen receptor alpha polymorphisms have any impact on the outcome in an ART program?

Authors:  Elli Anagnostou; Fotodotis Malamas; Despina Mavrogianni; Vasiliki Dinopoulou; Peter Drakakis; Konstantinos Kallianidis; Dimitris Loutradis
Journal:  J Assist Reprod Genet       Date:  2013-03-15       Impact factor: 3.412

10.  Cost analysis model of outpatient management of ovarian hyperstimulation syndrome with paracentesis: "tap early and often" versus hospitalization.

Authors:  John M Csokmay; Belinda J Yauger; Melinda B Henne; Alicia Y Armstrong; John T Queenan; James H Segars
Journal:  Fertil Steril       Date:  2008-11-05       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.